In the last 8 years, stents have been used with increasing frequency in con
genital heart disease. They have been used in branch pulmonary artery steno
sis, whether naturally occurring or post-surgical, native coarctation and a
ortic recoarctation after previous surgery and systemic venous stenoses, wh
ich usually occur after surgery. In all these indications, stents produce a
more predictable dilation, preventing vessel recoil. However, longer follo
w-up studies are required to determine if they are likely to cause future p
roblems of management, such as development of stenosis within the stent due
to intimal proliferation.